SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-118546
Filing Date
2018-04-16
Accepted
2018-04-16 16:16:04
Documents
9
Period of Report
2018-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d578672d8k.htm 8-K 24941
2 EX-4.1 d578672dex41.htm EX-4.1 64656
3 EX-4.2 d578672dex42.htm EX-4.2 67598
4 EX-10.1 d578672dex101.htm EX-10.1 128006
5 EX-10.2 d578672dex102.htm EX-10.2 70642
6 EX-10.3 d578672dex103.htm EX-10.3 52188
7 EX-99.1 d578672dex991.htm EX-99.1 5828
8 GRAPHIC g5786723.jpg GRAPHIC 10613
9 GRAPHIC g578672g03f76.jpg GRAPHIC 4298
  Complete submission text file 0001193125-18-118546.txt   435817
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 18756789
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1